Case’s descriptions
All cases reported here are from female patients’ residents in Manaus, Amazonas state capital city, Brazil, with no travel history. All patients reported less severe illness in the second infection. Detailed descriptions for each event are shown.
Case 1
A 29-year-old patient presented two clinical episodes of COVID-19 infection 281 days apart (Figure 1 - Case 1). The first episode on 16th March 2020 evolved with long-term fever and myalgia, cough, sore throat, nausea, and back pain. The patient was classified as having mild COVID-19 with no complications regarding these clinical manifestations and based on imaging exams. On 19th December 2020, the patient reported participating in an end-of-year celebration with ten other colleagues after testing positive in an IgG rapid test (Medlevensohn, RJ, Brazil) that uses the spike protein antigen. One of the meeting participants was RT-PCR confirmed for SARS-CoV-2 infection on 24th December, and the case 1 patient exhibited the second symptomatic COVID-19 episode on 27th December, with fever, cough, sore throat, diarrhea, anosmia, ageusia, headache, runny nose, and resting pulse oximetry of 97%.
Case 2
A 50-year-old subject presented two clinical episodes of COVID-19 infection 92 days apart (Figure 1 – Case 2). Interestingly, the patient participated in a COVID-19 serum epidemiological survey, testing negative for IgM and IgG only three days before the first symptoms onset. On 16th October 2020, presented fever, cough, and tiredness, being RT-PCR confirmed on 19th October 2020 and classified as having mild COVID-19 with no complications and did not perform imaging exams. The patient had an RT-PCR negative result on 5th November 2020 and a positive IgM/IgG rapid test result (Biomanguinhos, RJ, Brazil) on 23rd November 2020. The second symptomatic episode of mild COVID-19 raised on 16th January 2021 with cough, headache, and runny nose, without further complications.
Case 3
The third suspected reinfection case was a 40-year-old woman who presented two clinical episodes of mild COVID-19 infection 282 days apart (Figure 1 – Case 3). On 21st April 2020, she presented fever, headache, chest pain, and weakness, being RT-PCR confirmed on 22nd April 2020. No further complications were reported and on 15th May 2020, the patient had a negative SARS-CoV-2 RT-PCR test. The subject received a kidney transplant 11 years ago and is evaluated periodically in another Brazilian state. For that reason, she needed a negative RT-PCR certificate as a prerequisite for boarding. However, even asymptomatic, SARS-CoV-2 RNA was detected on 29th January 2021, one day before presenting sore throat and running nose symptoms.
Procedures
All patients had nasopharyngeal and pharyngeal swabs (NPS) collected by Fiocruz Amazônia (Fiocruz/ILMD) staff, which is part of the official network of the Ministry of Health for diagnostics and surveillance of the SARS-CoV-2 in the Amazonas state, Brazil. Briefly, total nucleic acid was extracted from the NPS specimens with Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Promega, Madison, WI) and then immediately the RNA was submitted to the SARS-CoV-2 real time RT-PCR protocol detection developed by the US CDC, targeting the viral N gene, and human RNase P as the internal control 15.
For NGS, the whole-genome amplicons were generated as previously described 16, but now with a PCR scheme encompassing nine overlapping amplicons (Supplemental file - Supplementary table 1 and 2). Libraries were produced with Nextera XT and sequenced with MiSeq Reagent Micro Kit v2 (300-cycles). The FASTQ reads were obtained following the Illumina pipeline on BaseSpace, imported into Geneious v10.2.6, trimmed (BBDuk 37.25), and mapped (BBMap 37.25) against the reference sequence EPI_ISL_402124 available in EpiCoV database from GISAID (https://www.gisaid.org/).
In order to confirm the presence of phylogenetically different SARS-CoV-2 lineages in each episode, sequences from the suspected reinfections cases were aligned with all high quality (<1% of N) SARS-CoV-2 whole-genomes (>29 kb) from Brazil available in the EpiCoV database in GISAID by February 12th, 2021. Phylogenetic analysis was initially performed using ML with IQ-TREE v2.1.2 17 and the temporal scale of lineage P.1 viral strains associated with the reinfection cases was reconstructed using a Bayesian analysis with BEAST 1.10 18. The time-scaled P.1 phylogeny was estimated using a strict molecular clock model with a uniform substitution rate prior (8-10 ⨉ 10-4 substitutions/site/year), the GTR+I+G4 nucleotide substitution model and the Bayesian skyline coalescent prior.
This study followed the guidelines of the SARS-CoV-2 surveillance program of the Amazonas State Health Secretariat and was approved by the Ethics Committee of the Amazonas State University CAAE: 25430719.6.0000.5016.